Cheshire, UK--(Marketwire - October 8, 2007) -
Protherics PLC
6 monthly Block Listing Return
Approved Executive Share Option Scheme
London, UK; Brentwood, TN; 8 October 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that, today, the following 6 monthly block listing return in respect of the Company's Approved Executive Share Option Scheme has been lodged with the FSA in accordance with Listing Rule 3.5.6.
Name of applicant: Protherics PLC
Name of scheme: Protherics PLC Approved Executive
Share Option Scheme
Period of return: From: 9 April 2007
To: 8 October 2007
Balance under scheme from previous
return: 335,299
The amount by which the block
scheme has been increased, if the
scheme has been increased since
the date of the last return: Nil
Number of securities
issued/allotted under scheme
during period: 34,997
Balance under scheme not yet
issued/allotted at end of period: 300,302
Number and class of securities
originally listed and the 387,712 Ordinary Shares (date of
date of admission: admission: 8 April 2005)
Total number of securities in
issue at the end of the period: 339,346,822
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0) 1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, David Yates +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange